The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines [Editorial]
dc.check.date | 2020-03-03 | |
dc.check.info | Access to this article is restricted until 12 months after publication by request of the publisher. | en |
dc.contributor.author | Griffin, Brendan T. | |
dc.contributor.author | Dressman, Jennifer B. | |
dc.contributor.funder | Horizon 2020 | en |
dc.date.accessioned | 2019-03-15T10:44:25Z | |
dc.date.available | 2019-03-15T10:44:25Z | |
dc.date.issued | 2019-03-03 | |
dc.date.updated | 2019-03-15T10:30:58Z | |
dc.description.status | Peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Griffin, B. T. and Dressman, J. B. (2019) 'The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines', Journal of Pharmacy and Pharmacology, 71(4), pp. 439-440. doi:10.1111/jphp.13083 | en |
dc.identifier.doi | 10.1111/jphp.13083 | |
dc.identifier.endpage | 440 | en |
dc.identifier.issn | 0022-3573 | |
dc.identifier.issn | 2042-7158 | |
dc.identifier.issued | 4 | en |
dc.identifier.journaltitle | Journal of Pharmacy and Pharmacology | en |
dc.identifier.startpage | 439 | en |
dc.identifier.uri | https://hdl.handle.net/10468/7631 | |
dc.identifier.volume | 71 | en |
dc.language.iso | en | en |
dc.publisher | John Wiley & Sons, Inc. | en |
dc.relation.project | info:eu-repo/grantAgreement/EC/H2020::MSCA-ITN-ETN/674909/EU/Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines/PEARRL | en |
dc.relation.uri | https://onlinelibrary.wiley.com/doi/abs/10.1111/jphp.13083 | |
dc.rights | © 2019, Royal Pharmaceutical Society of Great Britain. Published by John Wiley & Sons, Inc. All rights reserved. This is the peer reviewed version of the following article: Griffin, B. T. and Dressman, J. B. (2019) 'The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines', Journal of Pharmacy and Pharmacology, 71(4), pp. 439-440. doi:10.1111/jphp.13083, which has been published in final form at https://doi.org/10.1111/jphp.13083. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. | en |
dc.subject | Oral medicine | en |
dc.subject | Solubility | en |
dc.subject | PBPK | en |
dc.subject | Bio-enabling formulation | en |
dc.title | The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines [Editorial] | en |
dc.type | Other | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- FOREWORD_special_issue_28_JAN_2019.pdf
- Size:
- 111.8 KB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted Version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: